The genome editing tool CRISPR–Cas9 – which plays a critical role in EMBL’s research – was recognised by the Nobel Prize in…
Scientists at EMBL Heidelberg have investigated stem cells and how they differentiate to become neurons. Their approach included an assessment of the…
A study conducted by the Hackett group at EMBL Rome has identified key factors controlling the complex system of gene regulation during early embryo…
EMBL scientists develop a new molecular tool to prevent SARS-CoV-2 infection in mice. This tool is able to cause targeted epigenetic modifications of…
Scientists at EMBL Heidelberg have developed a new method, called Targeted Perturb-seq (TAP-seq), which increases the scale and precision of…
Researchers from the Sharpe group at EMBL Barcelona have published a method to track the developmental history of a cell using the gene editing tool…
EMBL scientists examine the molecular causes of a rare hereditary disease of the spine and…
Committee recognises outstanding contributions of EMBL alumni to science journalism and genome…
Exploring the diverse routes by which EMBL scientists are driving forward…
What CRISPR may bring for the future of biology, and how it is used at…
Large CRISPR screen prioritises hundreds of promising genes for personalised cancer…
EMBL’s GeneCore steps up to discover the facts and settle…
Looking for past print editions of EMBLetc.? Browse our archive, going back 20 years.
EMBLetc. archive